\nTeva Pharmaceuticals\u2019 legacy of innovation spans over 120 years. The company\u2019s mission to deliver quality medicine is rooted in the belief that \u201cWhen it comes to health and the people we serve, good is not enough for us\u201d \u2014 a standard that recently shaped its approach to transforming medical information.\n<\/p>\n
\nFew functions are as interconnected as medical information. Every system decision carries weight upstream and downstream. Deciding to change isn\u2019t easy and never happens on a whim. It requires careful consideration, coordination, and commitment to a long-term vision. Teva realized the status quo wasn\u2019t enough and keeping things as-is meant falling behind.\n<\/p>\n
\nSeven years ago, Teva invested in a global medical information system to unify siloed operations across the United States, Europe, and International Markets countries. At the time, it was a milestone. But quickly, persistent technology issues and limitations began to hold the organization back. Challenges with customer service, a lack of connection with critical systems, and Teva\u2019s long-term strategic path to implement and connect data and processes cross functionally signaled a need for change. “There’s no compromise when it comes to compliance. We needed a better platform and a partner who could deliver on Teva\u2019s long-term goals and objectives,\u201d says Susan Larijani, senior director of medical information at Teva.<\/p>\n
\nThe organization launched an RFP process guided by its long-term IT roadmap. The evaluation criteria prioritized scalability, seamless connectivity, and automation to strengthen data integrity across platforms.<\/p>\n
\nTeva\u2019s decision to select Veeva MedInquiry<\/a> as its global medical information system was a collaborative one. Global IT and Medical Affairs participated in the RFP process, with input from a cross-functional global medical team and select commercial partners. Global IT made the final decision in partnership with the SVP and Head of Global Medical Affairs, Todd Fox. Ultimately, MedInquiry offered the best fit for both business and technical requirements.\n<\/p>\n \n\u201cOur transition to Veeva MedInquiry reflects a broader commitment as a critical interface with – Todd Fox, SVP, head of global medical affairs, Teva<\/span>\n<\/p><\/blockquote>\n \nIn 2024, Teva simultaneously onboarded all regions to MedInquiry, completing global implementation in just nine months. The rollout marked Veeva\u2019s fastest for a large biopharma and set a new standard for execution at scale.\n<\/p>\n \nKey project highlights include:<\/strong><\/p>\n \nImplementing large-scale, global projects can be complex. Teva knew from the outset that unifying a comprehensive, global product list would be one of its biggest hurdles. \u201cWe expected this challenge since we manage an extensive list of globally marketed products,\u201d says Larijani. \u201cTake amoxicillin for instance: you could have amoxicillin suspension, amoxicillin for injection, amoxicillin capsules, amoxicillin tablets. We had to import all of these products in the database,\u201d she explains.\n<\/p>\n \nTo address this challenge, Veeva customized a solution for Teva by extending the \u201cProduct\u201d field with the addition of a \u201cProduct Details\u201d field. \u201cIt was great working with the Veeva team. They went back to the drawing board and delivered a solution,\u201d says Larijani. \u201cWe then worked internally to import our 5000 plus product details into MedInquiry to ensure access by all countries and consistency in how products are entered in the system. It\u2019s working really well for us.\u201d\n<\/p>\n \nWith MedInquiry live, the benefits of a fully connected ecosystem became clear almost immediately. Seamless integration with other Veeva solutions enabled new levels of automation, visibility, and responsiveness. Two in particular, according to Larijani, have delivered significant impact.\n<\/p>\n
\nthe global healthcare ecosystem in advancing how we deliver Medical Information \u2014 ensuring our teams are equipped to meet rising expectations across global markets.\u201d<\/p>\nExecuting a global go-live across 5,000+ products<\/h2>\n
\n
Realizing quick wins through connection<\/h2>\n
Automating adverse event triage and reconciliation<\/h3>\n